Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety and pharmacokinetics of a three-drug combination (dapagliflozin, linagliptin, and metformin) in healthy adults; not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)
• Glucophage (metformin)
• Tradjenta (Linagliptin)

Snippet

Sponsor: AJU Pharm Co., Ltd. | Conditions: Type2 Diabetes Mellitus | Phase 1 | Status: NOT_YET_RECRUITING